FlyteHealth, a New Canaan-based early cardio-kidney-metabolic (eCKM) care platform, achieved General Availability within the Centers for Medicare & Medicaid Services (CMS) Health Technology Ecosystem, making its Medicare-focused chronic disease care available to beneficiaries nationwide.
FlyteHealth was recognized July 27 at the initiative's one-year anniversary event at the Hubert H. Humphrey Building in Washington, D.C., hosted by the U.S. Department of Health and Human Services and CMS.
The designation confirms FlyteHealth's solution meets CMS's rigorous patient-facing requirements and is live for Medicare beneficiaries, building on its June 2026 Diabetes and Obesity category selection.
Ishraf Ahmad, Chief Product and Technology Officer of FlyteHealth, said, "Reaching General Availability meant clearing some of the highest bars in digital health — verified identity at the IAL2 level, secure access to health records from CMS-Aligned Networks without a single portal login, and complete patient control over what data is shared. Our team delivered all of it, and the result is an experience where a beneficiary's actual health records — labs, conditions, and medications — power personalized care from the very first visit."
FlyteHealth's model is independently validated: a Milliman analysis found 86% adherence at 12 months and 16.6% average weight loss, alongside improvements in blood pressure, A1c, and LDL cholesterol.
"General Availability means Medicare beneficiaries can access FlyteHealth today," said Darin Moore, Chief Commercial Officer of FlyteHealth. "For our health plan and employer partners, it is independent confirmation that our eCKM platform meets CMS's bar for connected, patient-first care."
A 2026 Segal Group evaluation of the State of Connecticut Health Plan found approximately $100 per member per month in medical cost avoidance and $29.7 million in pharmacy cost avoidance. FlyteHealth was also featured by CMS ahead of the Medicare ACCESS Model launch, highlighting its scalable approach to eCKM care.
